Utility:
| This study compared results from the Euroimmun myositis line blot panel to the Oklahoma Medical Research Foundations (OMRF) myositis panel on a cohort of patients that represent dermatomyositis, polymyositis and immune-mediated necrotizing myopathy. When using the Euroimmun line blot different thresholds or cutoffs were required to achieve the best kappa statistics, thus complicating interpretation. |